You are here

  • Home
  • Archive
  • Volume 13, Issue Suppl 1
  • BASELINE BREAST CANCER RISK DEMOGRAPHICS AND METHODOLOGY FOR THE RALOXIFENE USE FOR THE HEART (RUTH) AND CONTINUING OUTCOMES RELEVANT TO EVISTA (CORE) STUDIES, TWO BREAST CANCER PREVENTION TRIALS

Article Text

Article menu
Download PDFPDF
ABSTRACTS: PLENARY SESSIONS: Session 2 – Breast and Uterine Sarcoma
BASELINE BREAST CANCER RISK DEMOGRAPHICS AND METHODOLOGY FOR THE RALOXIFENE USE FOR THE HEART (RUTH) AND CONTINUING OUTCOMES RELEVANT TO EVISTA (CORE) STUDIES, TWO BREAST CANCER PREVENTION TRIALS

http://dx.doi.org/10.1136/ijgc-00009577-200303001-00007

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    PDF extract preview

    This is a PDF-only article. The first page of the PDF of this article appears above.